Chief Financial Officer
Tue, Dec 9, 2025
Dec 9
exercised or converted securities in PCRX
15,896 shares @ $16.45
Increased holdings by +28.30%
Net across this filing: 0.00% (+0 shares)
Option Exercise
Sale tied to a same-time option exercise
PCRXPacira BioSciences, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W+4.02%
1M-7.55%
3M—
6M—
1Y—